1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Akeso: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer AK105, carboplatin, pemetrexed - Lung Cancer Non-small Cell Stage IV | Phase 3 | Terminated | Akeso | 164 | 2018-11-27 | 2024-04-03 |
Carcinoma, Non-Small-Cell Lung (1)
Carboplatin (1) · Pemetrexed (1) · anlotinib (1)
China (1)
Baohui Han, MD (1) · Shunchang Jiao, MD (1)